On May 1, the US Department of Health and Human Services released “Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices,” which was commissioned by a Trump administration Executive Order. This comprehensive review assesses current evidence on treating paediatric gender dysphoria, emphasizing the importance of compassionate, evidence-based care tailored to children’s and adolescents’ needs. It highlights the risks of paediatric medical transitions, questioning their benefits and critiquing the “gender-affirming” model of care used in the US. The review also discusses ethical considerations, advocating for psychotherapy as a safer alternative. It aims to inform policymakers, clinicians, and families amid growing international concern about paediatric medical transitions.